Skip to main content
SpringerLink
Log in

Metabolic liver diseases presenting as acute liver failure in children

  • Review Article
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Context

Suspecting metabolic liver disease in an infant or young child with acute liver failure, and a protocol-based workup for diagnosis is the need of the hour.

Evidence acquisition

Data over the last 15 years was searched through Pubmed using the keywords “Metabolic liver disease” and “Acute liver failure” with emphasis on Indian perspective. Those published in English language where full text was retrievable were included for this review.

Results

Metabolic liver diseases account for 13-43% cases of acute liver failure in infants and young children. Etiology remains indeterminate in very few cases of liver failure in studies where metabolic liver diseases were recognized in large proportion. Galactosemia, tyrosinemia and mitochondrial disorders in young children and Wilson’s disease in older children are commonly implicated. A high index of suspicion for metabolic liver diseases should be kept when there is strong family history of consanguinity, recurrent abortions or sibling deaths; and history of recurrent diarrhea, vomiting, failure to thrive or developmental delay. Simple dietary modifications and/or specific management can be life-saving if instituted promptly.

Conclusions

A high index of suspicion in presence of red flag symptoms and signs, and a protocol-based approach helps in timely diagnosis and prompt administration of lifesaving therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alam S, Lal BB, Khanna R, Sood V, Rawat D. Acute liver failure in infants and young children in a specialized pediatric liver centre in India. Indian J Pediatr. 2015 Jan 6. [Epub ahead of print].

    Google Scholar 

  2. Rajanayagam J, Coman D, Cartwright D, Lewindon PJ. Pediatric acute liver failure: Etiology, outcomes, and the role of serial pediatric end-stage liver disease scores. Pediatr Transplant. 2013;17: 362–8.

    Article  CAS  PubMed  Google Scholar 

  3. Brett A, Pinto C, Carvalho L, Garcia P, Diogo L, Gonçalves I. Acute liver failure in under two year-olds–are there markers of metabolic disease on admission? Ann Hepatol. 2013;12: 791–6.

  4. Sundaram SS, Alonso E, Narkewicz MR, Zhang S, Squires RH and Pediatric Acute Liver Failure Study Group. Characterization and outcome of young infants with acute liver failure. J Pediatr. 2011;159: 813–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dhawan A. Etiology and prognosis of acute liver failure in children. Liver Transplant. 2008;14:S80–S4.

    Article  Google Scholar 

  6. Squires RH, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: The first 348 patients in pediatric acute liver failure study group. J Pediatr. 2006;148: 652–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Durand P, Debray D, Mandel R, Baujard C, Branchereau S, Gauthier F, et al. Acute liver failure in infancy: A 14-year experience of a pediatric liver transplantation center. J Pediatr. 2001;139: 871–6.

    Article  CAS  PubMed  Google Scholar 

  8. Kaur S, Kumar P, Kumar V, Sarin SK, Kumar A. Etiology and prognostic factors of acute liver failure in children. Indian Pediatr. 2013;50: 677–9.

    Article  PubMed  Google Scholar 

  9. Lee WS, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Pediatr Gastroenterol Nutr. 2005;40: 575–81.

    Article  PubMed  Google Scholar 

  10. Shanmugam NP, Bansal S, Greenough A, Verma A, Dhawan A. Neonatal liver failure-etiologies and management-state of the art. Eur J Pediatr. 2011;170: 573–81.

    Article  CAS  PubMed  Google Scholar 

  11. Narkewicz MR, DellOlio D, Karpen SJ, Murray KF, Schwarz K, Yazigi N, et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr. 2009;155: 801–6.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Poddar U, Thapa BR, Prasad A, Sharma AK, Singh K. Natural history and risk factors in fulminant hepatic failure. Arch Dis Child. 2002;87: 54–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr. 1998;132: 924–33.

    Article  CAS  PubMed  Google Scholar 

  14. Dimmock DP, Zhang Q, Dionisi-Vici C, Carrozzo R, Shieh J, Tang LY, et al. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat. 2008;29: 330–1.

    Article  CAS  PubMed  Google Scholar 

  15. Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology. 2008;48: 1167–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Eurpean Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson’s disease. J Hepatol. 2012;56: 671–85.

    Article  Google Scholar 

  17. Rahimi RS, Singal AG, Cuthbert JA, Rockey DC. Lactulose vs polyethylene glycol 3350–electrolyte solution for treatment of overt hepatic encephalopathy: The HELP randomized clinical trial. JAMA Intern Med. 2014;174: 1727–33.

    Article  CAS  PubMed  Google Scholar 

  18. Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: Systematic review of randomised trials. BMJ. 2004;328: 1046.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Leise MD, Poterucha JJ, Kamath PS, Kim WR. Management of hepatic encephalopathy in the hospital. Mayo Clin Proc. 2014;89: 241–53.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Alba L, Hay JE, Angulo P, Lee WM. Lactulose therapy in acute liver failure. J Hepatol. 2002;36: 33A.

    Article  Google Scholar 

  21. Sushma S, Dasarathy S, Tandon RK, Jain S, Gupta S, Bhist MS. Sodium benzoate in the treatment of acute hepatic encephalopathy: A double-blind randomized trial. Hepatology. 1992;16: 138–44.

    Article  CAS  PubMed  Google Scholar 

  22. Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK, et al. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med. 1982;306: 1387–92.

    Article  CAS  PubMed  Google Scholar 

  23. Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, et al. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant. 2011;26: 3633–9.

    Article  CAS  PubMed  Google Scholar 

  24. Liu JP, Gluud LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure. Cochrane Database Syst Rev. 2004;1:CD003628.

    PubMed  Google Scholar 

  25. Bourgoin P, Merouani A, Phan V, Litalien C, Lallier M, Alvarez F, et al. Molecular absorbent recirculating system therapy (MARS) in pediatric acute liver failure: A single center experience. Pediatr Nephrol. 2014;29: 901–8.

    Article  PubMed  Google Scholar 

  26. Lai YC, Huang HP, Tsai IJ, Tsau YK. High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children. Blood Purif. 2007;25: 303–8.

    Article  PubMed  Google Scholar 

  27. Westrope C, Morris K, Burford D, Morrison G. Continuous hemofiltration in the control of neonatal hyperammonemia: A 10-year experience. Pediatr Nephrol. 2010;25: 1725–30.

    Article  PubMed  Google Scholar 

  28. Mazariegos G, Shneider B, Burton B, Fox IJ, Hadzic N, Kishnani P, et al. Liver transplantation for pediatric metabolic diseases. Mol Genet Metab. 2014;111: 418–27.

    Article  CAS  PubMed  Google Scholar 

  29. Arnon R, Kerkar N, Davis MK, Anand R, Yin W, González-Peralta RP, et al. Liver transplantation in children with metabolic diseases: The studies of pediatric liver transplantation experience. Pediatr Transplant. 2010;14: 796–805

    Article  PubMed  Google Scholar 

  30. Stevenson T, Millan MT, Wayman K, Berquist WE, Sarwal M, Johnston EE, et al. Long-term outcome following pediatric liver transplantation for metabolic disorders. Pediatr Transplant. 2010;14: 268–75.

    Article  PubMed  Google Scholar 

  31. Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson’s disease in children: 37-year experience and revised King’s score for liver transplantation. Liver Transplant. 2005;11: 441–8.

    Article  Google Scholar 

  32. Devarbhavi H, Singh R, Adarsh CK, Sheth K, Kiran R, Patil M. Factors that predict mortality in children with Wilson disease associated acute liver failure and comparison of Wilson disease specific prognostic indices. J Gastroenterol Hepatol. 2014;29: 380–6.

    Article  CAS  PubMed  Google Scholar 

  33. Fischer RT, Soltys KA, Squires RH, Jaffe R, Mazariegos GV, Shneider BL. Prognostic scoring indices in Wilson disease: A case series and cautionary tale. J Pediatr Gastroenterol Nutr. 2011;52: 466–9.

    Article  PubMed  Google Scholar 

  34. Hughes RD, Mitry RR, Dhawan A. Current status of hepatocyte transplantation. Transplantation. 2012;93: 342–7.

    Article  CAS  PubMed  Google Scholar 

  35. Sokal EM. Treating inborn errors of liver metabolism with stem cells: Current clinical development. J Inherit Metab Dis. 2014;37: 535–9.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Cantz T, Sharma AD, Ott M. Concise review: Cell therapies for hereditary metabolic liver diseases -concepts, clinical results and future developments. Stem Cells. 2015;33: 1055–62.

    Article  CAS  PubMed  Google Scholar 

  37. De-Laet C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell G, Monti L, et al. Recommendations for the management of tyrosinemia type 1. Orphanet J Rare Dis. 2013; 8:8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India

    Seema Alam & Bikrant Bihari Lal

  2. Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110 070, India

    Seema Alam

Authors
  1. Seema Alam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bikrant Bihari Lal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seema Alam.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alam, S., Lal, B.B. Metabolic liver diseases presenting as acute liver failure in children. Indian Pediatr 53, 695–701 (2016). https://doi.org/10.1007/s13312-016-0913-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-016-0913-1

Keywords

Search

Navigation